AppLovin offers to buy video game software maker Unity in $17.5 bln deal

AppLovin offers to buy video game software maker Unity in $17.5 bln deal

People play “Pokemon GO” on the Pokequan GoBoat Adventure Cruise in the Occoquan River in the small town of Occoquan, Virginia, U.S. August 14, 2016. REUTERS/Sait Serkan GurbuzRegister now for FREE unlimited access to Reuters.comRegisterAug 9 (Reuters) – Gaming software company AppLovin Corp (APP.O) made an offer on Tuesday to buy its peer Unity Software Inc (U.N) in a $17.54 billion all-stock deal, threatening to derail Unity’s announced plan to acquire AppLovin’s smaller competitor ironSource .AppLovin has offered $58.85 for each Unity share, which represents a premium of 18% to Unity’s Monday closing price. Unity will own 55% of the combined company’s outstanding shares, representing about 49% of the voting rights.AppLovin hired advisors to work out an offer after Unity last month said it would buy ironSource in a $4.4 billion all-stock transaction, sources familiar with the matter told Reuters. Unity’s board will have to terminate the ironSource deal if it wants to pursue a combination with AppLovin, according to the proposal.Register now for FREE unlimited access to Reuters.comRegisterUnder the proposed deal, Unity’s Chief Executive John Riccitiello will become CEO of the combined business, while AppLovin Chief Executive Adam Foroughi will take the role of chief operating officer.Unity said its board would evaluate the offer. The company is slated to report its earnings after the bell on Tuesday.Both companies make software used to design video games. Game-making software has also been expanding to new technologies such as the so-called metaverse, or immersive virtual worlds.Unity’s software has been used to build some of the most-played games such as “Call of Duty: Mobile,” and “Pokemon Go”, while AppLovin provides helps developers to grow and monetize their apps.AppLovin’s offer comes as game developers and console makers warn of a slowdown in the sector as decades-high inflation and easing of COVID-19 restrictions lead gamers to pick outdoor activities. The company lowered its sales guidance on Tuesday.”The deal comes as surprise to everybody in the business,” said Serkan Toto, founder of game industry consultancy Kantan Games. “It’s a $15 billion company going after a $15 billion company. It’s a desperate attempt to consolidate and the chances of this deal happening are very slim.”Shares of Palo Alto, California-based AppLovin, which went public last year, fell 9.9% while those of Unity rose 1% in the morning trading session. Shares of ironSource were down 9.7%.Foroughi said the combined company will have the potential to generate an adjusted operating profit of over $3 billion by the end of 2024.Register now for FREE unlimited access to Reuters.comRegisterReporting by Eva Mathews and Nivedita Balu in Bengaluru, Krystal Hu in New York; Editing by Saumyadeb Chakrabarty and Mike HarrisonOur Standards: The Thomson Reuters Trust Principles. .

Analysis: Private equity’s swoop on listed European firms runs into rising execution risks

Analysis: Private equity’s swoop on listed European firms runs into rising execution risks

  • Boards, shareholders start to rail against lowball bids
  • Push for higher premiums compound debt funding dilemma
  • Buyer vs seller valuation gaps may take a year to close

LONDON, June 28 (Reuters) – European listed companies have not been this cheap for more than a decade, yet for private equity firms looking to put their cash piles to work, costlier financing and stronger resistance from businesses are complicating dealmaking.Sharp falls in the value of the euro and sterling coupled with the deepest trading discounts of European stocks versus global peers seen since March 2009, have fuelled a surge in take-private interest from cash-rich buyout firms.Private equity-led bids for listed companies in Europe hit a record $73 billion in the first six months of this year to date, more than double volumes of $35 billion in the same period last year and representing 37% of overall private equity buyouts in the region, according to Dealogic data.Register now for FREE unlimited access to Reuters.comRegisterThat contrasts with a sharp slowdown in overall M&A activity around the world. But as take-private target companies and their shareholders are increasingly bristling against cheap punts which they say fail to reflect fair value of their underlying businesses in 2022, prospects for deals in the second half of the year look less promising.Leading the first half bonanza was a 58 billion euro ($61.38 billion) take-private bid by the Benetton family and U.S. buyout fund Blackstone (BX.N) for Italian infrastructure group Atlantia (ATL.MI).Dealmakers, however, say the vast majority of take-private initiatives are not reflected in official data as many private equity attempts to buy listed companies have gone undetected with boardrooms shooting down takeover approaches before any firm bid has even been launched.”In theory it’s the right time to look at take-privates as valuations are dropping. But the execution risk is high, particularly in cases where the largest shareholder holds less than 10%,” said Chris Mogge, a partner at European buyout fund BC Partners.Other recent private equity swoops include a 1.6 billion pound ($1.97 billion) bid by a consortium of Astorg Asset Management and Epiris for Euromoney (ERM.L) which valued the FTSE 250-listed financial publisher at a 34% premium after four previous offers were rebuffed by its board. read more Also capturing the attention of private equity in recent weeks were power generating firm ContourGlobal (GLO.L), British waste-management specialist Biffa (BIFF.L) and bus and rail operator FirstGroup (FGP.L), with the latter rejecting the takeover approach. read more Trevor Green, head of UK equities at Aviva Investors (AV.L), said his team was stepping up engagement with company executives to thwart lowball bids, with unwelcome approaches from private equity made more likely in view of currency volatility.War in Europe, soaring energy prices and stagflation concerns have hit the euro and the British pound hard, with the former falling around 7% and the latter by 10% against the U.S. dollar this year.”We know this kind of currency movement encourages activity, and where there’s scope for a deal, shareholders will be rightly pushing for higher premiums to reflect that,” Green said.SUBDUED SPENDINGGlobally, private equity activity has eased after a record year in 2021, hit by raging inflation, recession fears and the rising cost of capital. Overall volumes fell 19% to $674 billion in the first half of the year, according to Dealogic data.Dealmaking across the board, including private equity deals, dropped 25.5% in the second quarter of this year from a year earlier to $1 trillion, according to Dealogic data. read more Buyout funds have played a major role in sustaining global M&A activity this year, generating transactions worth $405 billion in the second quarter.But as valuation disputes intensify, concerns sparked by rising costs of debt have prevented firms from pulling off deals for their preferred listed targets in recent months.Private equity firms including KKR, EQT and CVC Capital Partners ditched attempts to take control of German-listed laboratory supplier Stratec (SBSG.DE) in May due to price differences, three sources said. Stratec, which has a market value of 1.1 billion euros, has the Leistner family as its top shareholder with a 40.5% stake.EQT, KKR and CVC declined to comment. Stratec did not immediately return a request for comment.The risks of highly leveraged corporate takeovers have increased with financing becoming more expensive, leaving some buyers struggling to make the numbers on deals stack up, sources said.Meanwhile, piles of cash that private equity firms have raised to invest continue to grow, heaping pressure on partners to consider higher-risk deals structured with more expensive debt.”There is a risk premium for debt, which leads to higher deal costs,” said Marcus Brennecke, global co-head of private equity at EQT (EQT.N).The average yield on euro high yield bonds – typically used to finance leverage buyouts – has surged to 6.77% from 2.815% at the start of the year, according to ICE BofA’s index, and the rising cost of capital has slowed debt issuance sharply. (.MERHE00)As a result, private equity firms have increasingly relied on more expensive private lending funds to finance their deals, four sources said.But as share prices continue to slide, the gap between the premium buyers are willing to offer and sellers’ price expectations remains too wide for many and could take up to a year to narrow, two bankers told Reuters.In the UK, where Dealogic data shows a quarter of all European take-private deals have been struck this year, the average premium paid was 40%, in line with last year, according to data from Peel Hunt.”Getting these deals over the line is harder than it looks. The question really is going to be how much leverage (buyers can secure),” one senior European banker with several top private equity clients told Reuters.($1 = 0.8141 pounds)($1 = 0.9450 euros)Register now for FREE unlimited access to Reuters.comRegisterReporting by Joice Alves, Emma-Victoria Farr, Sinead Cruise, additional reporting by Yoruk Bahceli, editing by Pamela Barbaglia and Susan FentonOur Standards: The Thomson Reuters Trust Principles. .

Swedish Match top 10 investor says Philip Morris bid a ‘healthy premium’

Swedish Match top 10 investor says Philip Morris bid a ‘healthy premium’

Moist powder tobacco “snus” cans are seen on shelves at a Swedish Match store in Stockholm, Sweden October 24, 2018. Picture taken October 24, 2018. REUTERS/Anna Ringstrom/File PhotoRegister now for FREE unlimited access to Reuters.comRegisterLONDON, May 12 (Reuters) – Philip Morris’ $16 billion offer for Stockholm-based Swedish Match (SWMA.ST) represents a “healthy premium” and the Marlboro maker could yet go higher, Swedish Match’s No. 10 shareholder GACMO Investors (GBL.N) said on Thursday.Marlboro maker Philip Morris agreed on Wednesday to buy Swedish Match, one of the world’s biggest makers of oral nicotine products. These include Snus – a sucked tobacco product the firm says is less harmful than smoking – as well as Zyn nicotine pouches, which are used the same way and tobacco-free.Kevin Dreyer, co-chief investment officer, value, at GAMCO identified Japan Tobacco Inc (2914.T) (JTI) as a possible rival bidder but said it would be hard-pressed to hijack the deal. GAMCO, formerly known as Gabelli Asset Management Company, owns just over 2% of Swedish Match, according to Refinitiv.Register now for FREE unlimited access to Reuters.comRegister“PMI has very deep pockets and will be a tough company to out-bid,” he said. “This deal is really the culmination of the last five-to-seven years of work Swedish Match has done in developing Zyn into the leading brand, and having that advantageous market share – it’s an attractive stock.”Philip Morris declined to comment. Swedish Match and JTI did not immediately respond to a request for comment.Philip Morris needs at least 90% of shareholders to approve the deal for it to succeed. Some other shareholders have questioned whether the Philip Morris offer represents good value. Swedish Match shareholder Bronte Capital said on Wednesday the price Philip Morris agreed to pay was “unacceptable”.Register now for FREE unlimited access to Reuters.comRegisterReporting by Richa Naidu; editing by David Evans and Emelia Sithole-MatariseOur Standards: The Thomson Reuters Trust Principles. .

Analysis: Positive real yields may spell more trouble for U.S. stocks

Analysis: Positive real yields may spell more trouble for U.S. stocks

A street sign for Wall Street is seen in the financial district in New York, U.S., November 8, 2021. REUTERS/Brendan McDermid/File Photo/File PhotoRegister now for FREE unlimited access to Reuters.comRegisterNEW YORK, April 20 (Reuters) – A hawkish turn by the Federal Reserve is eroding a key support for U.S. stocks, as real yields climb into positive territory for the first time in two years.Yields on the 10-year Treasury Inflation-Protected Securities (TIPS) – also known as real yields because they subtract projected inflation from the nominal yield on Treasury securities – had been in negative territory since March 2020, when the Federal Reserve slashed interest rates to near zero. That changed on Tuesday, when real yields ticked above zero. Negative real yields have meant that an investor would have lost money on an annualized basis when buying a 10-year Treasury note, adjusted for inflation. That dynamic has helped divert money from U.S. government bonds and into a broad spectrum of comparatively riskier assets, including stocks, helping the S&P 500 (.SPX) more than double from its post-pandemic low.Register now for FREE unlimited access to Reuters.comRegisterAnticipation of tighter monetary policy, however, is pushing yields higher and may dent the luster of stocks in comparison to Treasuries, which are viewed as much less risky since they are backed by the U.S. government.Reuters GraphicsReuters GraphicsOn Tuesday, stocks shrugged off the rise in yields, with the S&P 500 ending up 1.6% on the day. Still, the S&P 500 is down 6.4% this year, while the yield on the 10-year TIPS has climbed more than 100 basis points.”Real 10-year yields are the risk-free alternative to owning stocks,” said Barry Bannister, chief equity strategist at Stifel. “As real yield rises, at the margin it makes stocks less attractive.”One key factor influenced by yields is the equity risk premium, which measures how much investors expect to be compensated for owning stocks over government bonds.Rising yields have helped result in the measure standing at its lowest level since 2010, Truist Advisory Services said in a note last week.Reuters GraphicsReuters GraphicsHEADWIND TO GROWTH SHARESHigher yields in particular dull the allure of companies in technology and other high-growth sectors, with those companies’ cash flows often more weighted in the future and diminished when discounted at higher rates.That may be bad news for the broader market. The heavy presence of tech and other growth stocks in the S&P 500 means the index’s overall expected dividends are weighted in the future at close to their highest level ever, according to BofA Global Research. Five massive, high-growth stocks, for example, now make up 22% of the weight of the S&P 500.At the same time, growth shares in recent years have been highly linked to the movement of real yields.Since 2018, a ratio comparing the performance of the Russell 1000 growth index (.RLG) to its counterpart for value stocks (.RLV) – whose cash flows are more near-term – has had a negative 96% correlation with 10-year real rates, meaning they tend to move in opposite directions from growth stocks, according to Ohsung Kwon, a U.S. equity strategist at BofA Global Research.Rising yields are “a bigger headwind to equities than (they have) been in history,” he said.Top five stocks market cap as percentage of S&P 500Top five stocks market cap as percentage of S&P 500Bannister estimates the S&P 500 could retest its lows of the year, which included a drop in March of 13% from the index’s record high, should the yield on the 10-year TIPS rise to 0.75% and the earnings outlook – a key component of the risk premium – remain unchanged.Lofty valuations also make stocks vulnerable if yields continue rising. Though the tumble in stocks has moderated valuations this year, the S&P 500 still trades at about 19 times forward earnings estimates, compared with a long-term average of 15.5, according to Refinitiv Datastream.“Valuations aren’t great on stocks right now. That means that capital may look at other alternatives to stocks as they become more competitive,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.Still, some investors believe stocks can survive just fine with rising real yields, for now. Real yields were mostly in positive territory over the past decade and ranged as high as 1.17% while the S&P 500 has climbed over 200%.JPMorgan strategists earlier this month estimated that equities could cope with 200 basis points of real yield increases. They advised clients maintain a large equity versus bond overweight.”If bond yield rises continue, they could eventually become a problem for equities,” the bank’s strategists said. “But we believe current real bond yields at around zero are not high enough to materially challenge equities.”Register now for FREE unlimited access to Reuters.comRegisterReporting by Lewis Krauskopf in New York
Editing by Ira Iosebashvili and Matthew Lewis
Our Standards: The Thomson Reuters Trust Principles. .

Ramsay Health Care gets $14.8 bln bid from KKR-led consortium; shares soar

Ramsay Health Care gets $14.8 bln bid from KKR-led consortium; shares soar

Trading information for KKR & Co is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., August 23, 2018. REUTERS/Brendan McDermidRegister now for FREE unlimited access to Reuters.comRegister

  • Ramsay receives A$88 cash per share proposal
  • Proposal at a 37% premium to Ramsay’s last close
  • Ramsay stock up 29.8% in early trade

April 20 (Reuters) – Ramsay Health Care Ltd (RHC.AX), Australia’s largest private hospital operator, said on Wednesday it received a A$20.05 billion ($14.80 billion) indicative takeover offer from a consortium led by private equity giant KKR & Co (KKR.N).The non-binding proposal of A$88 cash per share represents a premium of nearly 37% to Ramsay’s Tuesday closing price of A$64.39. The offer sent the hospital operator’s shares up as much as 29.8% to A$83.55 in early trade, their biggest-ever intraday jump.Ramsay said in a statement it would provide the KKR-led consortium with due diligence on a non-exclusive basis and talks were at a preliminary stage.Register now for FREE unlimited access to Reuters.comRegisterThe hospital operator said it had reviewed the proposal with its advisers and asked for further information from the consortium in relation to its funding and structure of the deal.KKR did not immediately respond to a Reuters request for comment.If successful, the takeover would be the biggest in Australia this year and nearly double deal activity, which at a total value of $17.4 billion, suffered a 41.2% decline in the first quarter compared with a year earlier, according to Refinitiv data.The proposal comes as record-low interest rates prompt private equity firms, superannuation and pension funds with ample liquidity to invest in healthcare and infrastructure assets.The deal would also rank as the second biggest private-equity backed in deal in Australia, following a consortium’s A$31.6 billion ($23.35 billion) enterprise value deal for Sydney airport last year. read more The pandemic hit healthcare operators including Ramsay, with the shutdown of non-urgent surgeries, staffing shortages due to isolation regulations, and upward wage pressure weighing on earnings and hurting stocks, making the sector relatively affordable for a buyout, compared to a few years ago.Last year, Australian biopharmaceutical giant CSL Ltd (CSL.AX) said it would buy Swiss drugmaker Vifor Pharma AG (VIFN.S) for $11.7 billion. read more Ramsay operates hospitals and clinics across 10 countries in three continents, with a network of more than 530 locations, according to its website.It has 72 private hospitals and day surgery units in Australia, while it operates clinics and primary care units in about 350 locations across six countries in Europe.KKR currently owns French healthcare group Elsan.Earlier this year, Ramsay and Malaysia’s Sime Darby Holdings received a $1.35 billion buyout offer from IHH Healthcare Bhd (IHHH.KL) for their Asia joint venture. Ramsay said it was still pursuing this transaction. The hospital operator has hired UBS AG’s Australia Branch and Herbert Smith Freehills as financial and legal advisers, respectively, for the KKR-led consortium’s proposal.($1 = 1.3535 Australian dollars)Register now for FREE unlimited access to Reuters.comRegisterReporting by Harish Sridharan in Bengaluru; additional reporting by Byron Kaye in Sydney; Editing by Sriraj Kalluvila, Aditya Soni and Krishna Chandra Eluri and Rashmi AichOur Standards: The Thomson Reuters Trust Principles. .